Related Experiment Video

Updated: May 3, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

8.3K

Alternative splicing in cancer: implications for biology and therapy

J Chen1, W A Weiss2

  • 11] Biomedical Sciences Graduate Program, University of California, San Francisco, CA, USA [2] Department of Neurology, University of California, San Francisco, CA, USA.

Oncogene
|January 21, 2014
PubMed

Insights

Alternative splicing plays a key role in cancer development. Aberrant splicing of genes like TP53, BARD1, and AR can drive cancer progression and offers new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Alternative splicing is crucial for normal development and cancer progression.
  • Aberrant splicing can lead to oncogene activation and tumor suppressor inactivation.
  • Altered splicing patterns correlate with cancer stage and malignancy progression.

Purpose of the Study:

  • To review the splicing landscape of key cancer-related genes (TP53, BARD1, AR).
  • To illuminate the roles of alternative splicing in cancer development and progression.
  • To examine the interplay between alternative splicing and emerging cancer therapies.

Main Methods:

  • Literature review of alternative splicing in cancer.
  • Analysis of splicing patterns in TP53, BARD1, and AR.
  • Examination of therapeutic strategies targeting splicing pathways.

Main Results:

  • Alternative splicing significantly impacts cancer pathways.
  • Aberrant splicing of TP53, BARD1, and AR contributes to oncogenesis.
  • Splicing alterations are linked to cancer stage and progression.

Conclusions:

  • Alternative splicing is a critical factor in cancer biology.
  • Targeting aberrant splicing pathways presents a promising therapeutic avenue.
  • Further research into splicing modulation could yield novel cancer treatments.

More Related Videos

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

12.5K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.4K

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.2K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.3K
RNA Splicing01:32

RNA Splicing

15.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K